Search

Search Results

• Ubiquitin-proteasome system is a sensitive target in Ph+ leukemia

  G Martinelli, D Cilloni, G Rosti, P Piccaluga, M Rondoni, C Bosi, S Paolini, F Pane, M Amabile, G Nadali, B Izzo

  2009-06-03

  https://doi.org/10.4081/hmr.v1i8.289

  216

  PDF: 272

• Pha-739358: a pan-aurora kinase inhibitor

  R Paquette, N Shah, C Sawyers, G Martinelli, J Nicoll, M Chalukya

  2009-06-23

  https://doi.org/10.4081/hmr.v2i5.743

  257

  Untitled: 0

  PDF: 442

• New drugs to overcome meccanisms of resistance in Ph+ leukemia: bosutinib

  G Martinelli, I Iacobucci, D Cilloni, P Giannoulia, S Soverini, PP Piccaluga, C Papayannidis, S Paolini, C Terragna

  2009-06-23

  https://doi.org/10.4081/hmr.v2i5.722

  236

  PDF: 225

• Thyrosin kinase inhibitors: nilotinib

  F Castagnetti, F Palandri, G Gugliotta, A Poerio, M Amabile, S Soverini, G Martinelli, M Baccarani, G Rosti

  2009-06-23

  https://doi.org/10.4081/hmr.v2i5.721

  384

  PDF: 455

• Refractory chronic lymphocytic leukemia

  Giovanni Martinelli

  2009-06-16

  https://doi.org/10.4081/hmr.v1i7.631

  225

  PDF: 437

• Azacytidine: first therapeutic opportunity for myelodysplastic syndromes

  C Finelli, C Bosi, G Martinelli, M Baccarani

  2009-06-08

  https://doi.org/10.4081/hmr.v2i7.415

  232

  PDF: 328